PLIANT THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pliant Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q3 2024.
  • Pliant Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $8.9M, a 14.1% decline year-over-year.
  • Pliant Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $38.4M, a 16.9% decline year-over-year.
  • Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $44.5M, a 96.8% increase from 2022.
  • Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $22.6M, a 117% increase from 2021.
  • Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10.4M, a 168% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $38.4M $8.9M -$1.46M -14.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $39.8M $10.6M -$2.4M -18.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $42.2M $9.67M -$2.26M -18.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $44.5M $9.15M -$1.71M -15.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $46.2M $10.4M +$5.56M +116% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $40.6M $13M +$9.64M +283% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $31M $11.9M +$8.39M +238% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $22.6M $10.9M +$8.09M +292% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $14.5M $4.81M +$2M +71% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $12.5M $3.4M +$1.12M +49.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $11.4M $3.53M +$953K +37% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $10.4M $2.77M +$1.25M +82.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $9.18M $2.81M +$1.64M +140% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $7.54M $2.28M +$1.49M +190% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $6.05M $2.58M +$2.15M +507% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $3.9M $1.52M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $1.17M +$689K +144% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $786K +$280K +55.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $425K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q3 2019 $480K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $506K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.